The Pediatric Research Equity Act aims to close the gap in pediatric drug testing but faces significant delays in study completion. Rare disease designations exempt nearly half of new drugs from ...

Please provide your email address to receive an email when new articles are posted on . Out of 323 drugs, only 10% completed testing in children before receiving FDA approval. Rare disease ...

The next innovation in cancer treatment could be to test all possible drugs on thousands of miniature versions of a person’s tumour, grown in the lab, to see which works the best. The technique, ...